EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers

Andreas Lau, Nghia Le, Claudia Nguyen, Raj P Kandpal

Cellular Signalling · 2023-04 · 104 · 110579

DOI: 10.1016/j.cellsig.2022.110579 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2023-04. Verfasst von Andreas Lau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA 91766, United States of America. Hauptthemen laut MEDLINE: Receptors, Eph Family, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: Western University of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eph receptors, the largest known family of receptor tyrosine kinases, and ephrin ligands have been implicated in a variety of human cancers. The novel bidirectional signaling events initiated by binding of Eph receptors to their cognate ephrin ligands modulate many cellular processes such as proliferation, metastasis, angiogenesis, invasion, and apoptosis. The relationships between the abundance of a unique subset of Eph receptors and ephrin ligands with associated cellular processes indicate a key role of these molecules in tumorigenesis. The combinatorial expression of these molecules converges on MAP kinase and/or AKT/mTOR signaling pathways. The intracellular target proteins of the initial signal may, however, vary in some cancers. Furthermore, we have also described the commonality of up- and down-regulation of individual receptors and ligands in various cancers. The current state of research in Eph receptors illustrates MAP kinase and mTOR pathways as plausible targets for therapeutic interventions in various cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Eph FamilyNeoplasmsHumansEphrinsProto-Oncogene Proteins c-aktLigandsMitogen-Activated Protein KinasesTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

Brain cancerBreast cancerColorectal cancerEph receptorsEphrin ligandsHuman cancersLung cancerMAPK pathwayProstate cancerReceptor tyrosine kinasesmTOR pathway

Substanzen

Receptors, Eph FamilyEphrinsProto-Oncogene Proteins c-aktLigandsMitogen-Activated Protein KinasesTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA 91766, United States of America.
  • Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA 91766, United States of America. Electronic address: rkandpal@westernu.edu.

Förderung

  • Western University of Health Sciences

Zitieren

APA

Lau, A., Le, N., Nguyen, C., & Kandpal, R. P. (2023). Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers. Cellular Signalling, 104, 110579. https://doi.org/10.1016/j.cellsig.2022.110579

Vancouver

Lau A, Le N, Nguyen C, Kandpal RP. Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers. Cellular Signalling. 2023;104:110579. doi:10.1016/j.cellsig.2022.110579

BibTeX
@article{Lau2023,
  author = {Lau, Andreas and Le, Nghia and Nguyen, Claudia and Kandpal, Raj P},
  title = {Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers},
  journal = {Cellular Signalling},
  year = {2023},
  volume = {104},
  pages = {110579},
  doi = {10.1016/j.cellsig.2022.110579}
}
Kostenlos starten →